Validation of Hand Held Dynamometer for Assessment of Lower Limb Muscle Strength in Multiple Sclerosis
Launched by BROWN, THEODORE R., M.D., MPH · Dec 12, 2012
Trial Information
Current as of July 06, 2025
Completed
Keywords
ClinConnect Summary
Purpose of this study is to assess the intra-rater and inter-rater reliability of a hand-held dynamometer (HHD) in the assessment of lower limb strength in patients with Multiple Sclerosis.
Also to establish a standardized strength testing procedure for key lower limb muscle groups using a HHD fo research and clinical purposes in Multiple Sclerosis.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Stable patients with clinically definite Multiple Sclerosis
- • No Multiple Sclerosis exacerbation 30 days prior to screening
- • No change in disease modifying therapy for 30 day prior to screening
- Exclusion Criteria:
- • Inflammatory myopathy
- • Endocarditis, pericarditis o rother unstable heart disease
- • Cardiac surgery or myocardial infarction in the last 3 months
- • Decompensated congestive heart failure
- • Severe aortic stenosis
- • Severe pulmonary hypertension
- • Pulmonary embolus or infarction in the last 6 months
- • Uncontrolled hypertension by history or by screening or baseline diastolic blood pressure \>170 or systolic blood pressure \>105
- • Concomitant neurodegenerative neurological disease such as Amyotrophic Lateral Sclerosis (ALS) Parkinsons or hemiplegic stroke
- • females who are pregnant
- • Cognitive deficits that would interfere with the subjects's ability to give informed consent or preform study testing
- • Painful orthopedic condition affecting the lower limbs
- • Any other serious and/or unstable medical condition
About Brown, Theodore R., M.D., Mph
Dr. Theodore R. Brown, M.D., MPH, is a distinguished clinical trial sponsor with extensive experience in medical research and public health. With a dual degree in medicine and public health, Dr. Brown is committed to advancing innovative therapeutic solutions through rigorous clinical studies. His expertise spans multiple therapeutic areas, emphasizing patient-centered approaches and ethical research practices. Dr. Brown's leadership in clinical trials is marked by a dedication to scientific integrity, collaboration with multidisciplinary teams, and a focus on translating research findings into meaningful healthcare improvements.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Kirkland, Washington, United States
Patients applied
Trial Officials
Theodore R Brown, MD
Principal Investigator
MS Center at Evergreen Hospital
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials